Rubicon Research Ltd.

NSE: RUBICON | BSE: 544578 | ISIN: INE506V01022 | Industry: Pharmaceuticals
| Expensive Performer
1420.2000 -16.40 (-1.14%)
NSE Oct 23, 2026 13:14 PM
Volume: 246.7K
 

1420.20
-1.14%

Four straight post-IPO beats; execution remains stellar

Motilal Oswal
Rubicon Research (RUBICON) delivered its fourth consecutive earnings surprise since its IPO (4%/13%/16% beat on revenue/EBITDA/PAT)—a strong pattern of promise vs consistent superior execution.
Rubicon Research has gained 52.06% in the last 6 Months
More from Rubicon Research Ltd.
Recommended